华北制药
(600812)
| 流通市值：88.87亿 | | | 总市值：88.87亿 |
| 流通股本：17.16亿 | | | 总股本：17.16亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 869,697,786.52 | 988,276,107.83 | 1,484,265,398.75 | 1,387,911,776.12 |
| 应收票据及应收账款 | 2,252,499,234.59 | 1,930,902,848.78 | 2,316,763,541.24 | 2,456,505,087.85 |
| 其中：应收票据 | - | - | 11,068,848 | 17,857,224 |
| 应收账款 | 2,252,499,234.59 | 1,930,902,848.78 | 2,305,694,693.24 | 2,438,647,863.85 |
| 应收款项融资 | 110,980,972.54 | 135,375,613.75 | 179,728,944.53 | 118,692,621.91 |
| 预付款项 | 276,599,840.4 | 282,427,824.35 | 307,773,799.66 | 329,437,657.08 |
| 其他应收款合计 | 1,619,632,826.21 | 1,902,203,194.48 | 1,963,829,171.13 | 1,955,058,993.29 |
| 其中:应收利息 | 6,669,820.78 | 4,834,666.63 | 3,985,333.29 | 3,126,666.64 |
| 存货 | 2,595,132,697.44 | 2,607,784,499.28 | 2,646,379,911.73 | 2,514,696,383.73 |
| 其他流动资产 | 183,233,327.19 | 170,620,975.11 | 185,771,716.47 | 185,901,796.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,907,776,684.89 | 8,017,591,063.58 | 9,084,512,483.51 | 8,948,204,316.52 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,209,670,133.05 | 1,202,161,386.57 | 1,189,851,970.65 | 920,374,963.51 |
| 其他权益工具投资 | 17,465,000 | 17,465,000 | 17,465,000 | 17,465,000 |
| 固定资产 | 6,575,283,297.49 | 6,446,830,948.81 | 6,423,425,058.56 | 6,517,070,201.59 |
| 在建工程 | 219,691,817.18 | 162,346,929.1 | 199,125,434.14 | 185,231,383.35 |
| 使用权资产 | 642,059,973.49 | 922,595,071.13 | 954,777,584.86 | 990,436,247.47 |
| 无形资产 | 1,942,997,325.9 | 1,974,821,364.14 | 1,683,190,335.66 | 1,671,850,296.61 |
| 开发支出 | 2,253,305,478.02 | 2,104,207,475.46 | 1,844,233,673.32 | 1,748,578,556.05 |
| 商誉 | 3,336,585.26 | 3,336,585.26 | 3,336,585.26 | 3,336,585.26 |
| 长期待摊费用 | 52,098,701.54 | 53,234,416.31 | 58,778,491.7 | 60,954,606.9 |
| 递延所得税资产 | 52,109,827.43 | 52,109,827.43 | 50,265,148.03 | 50,265,148.03 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 12,968,018,139.36 | 12,939,109,004.21 | 12,424,449,282.18 | 12,165,562,988.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 20,875,794,824.25 | 20,956,700,067.79 | 21,508,961,765.69 | 21,113,767,305.29 |
| 流动负债: | | | | |
| 短期借款 | 5,091,810,000 | 5,467,710,000 | 5,657,673,825.39 | 5,573,086,815.22 |
| 应付票据及应付账款 | 2,582,602,861.53 | 2,489,894,686.93 | 2,518,152,192.67 | 2,367,199,918.99 |
| 其中：应付票据 | 581,359,920.4 | 581,040,000 | 616,830,237 | 449,143,125.96 |
| 应付账款 | 2,001,242,941.13 | 1,908,854,686.93 | 1,901,321,955.67 | 1,918,056,793.03 |
| 合同负债 | 243,083,499.59 | 313,252,998.29 | 309,099,215.41 | 255,292,483.19 |
| 应付职工薪酬 | 180,395,438.76 | 176,880,926.47 | 179,845,395.67 | 174,175,433.48 |
| 应交税费 | 58,125,236.54 | 63,558,148.55 | 69,858,385.45 | 87,636,588.96 |
| 其他应付款合计 | 458,108,393.43 | 455,541,859.06 | 743,010,820.82 | 528,678,318.06 |
| 其中:应付利息 | 1,061,118.04 | 997,516.14 | 751,768.05 | 830,200.02 |
| 应付股利 | 385,687.5 | 385,687.5 | 385,687.5 | 385,687.5 |
| 一年内到期的非流动负债 | 1,150,747,554.55 | 1,299,861,845.99 | 1,558,355,467.44 | 2,016,483,683.84 |
| 其他流动负债 | 28,907,423.63 | 1,864,671.35 | 15,385,226.9 | 15,241,520.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 9,793,780,408.03 | 10,268,565,136.64 | 11,051,380,529.75 | 11,017,794,761.94 |
| 非流动负债: | | | | |
| 长期借款 | 4,486,600,885.84 | 4,080,858,283.77 | 3,791,295,906.09 | 3,399,006,900.42 |
| 租赁负债 | 256,571,618.15 | 299,161,001.6 | 362,108,128.53 | 394,887,984.94 |
| 长期应付款 | 900,000 | 900,000 | 900,000 | 900,000 |
| 递延收益 | 34,128,068.66 | 36,805,466.69 | 39,912,480.4 | 45,684,082.41 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,778,200,572.65 | 4,417,724,752.06 | 4,194,216,515.02 | 3,840,478,967.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 14,571,980,980.68 | 14,686,289,888.7 | 15,245,597,044.77 | 14,858,273,729.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 | 1,715,730,370 |
| 资本公积 | 3,899,134,148.47 | 3,899,134,148.47 | 3,886,387,018.14 | 3,886,387,018.14 |
| 其他综合收益 | 6,372,523.95 | 6,334,060.15 | 9,948,191.58 | 10,035,293.5 |
| 专项储备 | 1,281,671.48 | 710,521.11 | 1,803,252.64 | 1,424,133.78 |
| 盈余公积 | 322,436,110.73 | 322,436,110.73 | 295,007,501.13 | 295,007,501.13 |
| 未分配利润 | -610,889,206.29 | -629,041,653.38 | -578,530,297.3 | -579,957,810.86 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,334,065,618.34 | 5,315,303,557.08 | 5,330,346,036.19 | 5,328,626,505.69 |
| 少数股东权益 | 969,748,225.23 | 955,106,622.01 | 933,018,684.73 | 926,867,069.89 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,303,813,843.57 | 6,270,410,179.09 | 6,263,364,720.92 | 6,255,493,575.58 |
| 负债和股东权益合计 | 20,875,794,824.25 | 20,956,700,067.79 | 21,508,961,765.69 | 21,113,767,305.29 |
| 公告日期 | 2024-04-26 | 2024-03-30 | 2023-10-27 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |